Skip to Content
Merck

Obesity and atopy.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2014-10-18)
L-P Boulet
ABSTRACT

The prevalence of obesity has increased worldwide, and weight gain has been shown to influence the development and clinical expression of various conditions including asthma. The relationships between atopy and obesity remain uncertain, both in adults and in children. Although there are physiopathologic mechanisms which could explain how obesity could influence the immune system and promote the process of sensitization, evidences in favour of a possible role of obesity on the development of atopy have been inconsistent. Furthermore, the bulk of evidence suggests that atopy does not mediate the relationship between obesity and asthma, although in some populations, particularly in children and women, such association has been reported. Such lack of relationship has also been found with rhinoconjunctivitis although it has been observed for atopic dermatitis. Several factors may explain these variable results, including populational or environmental characteristics, socioeconomic status, confounding factors, in addition to sample size, and methodology of the performed studies. The possibility that obesity influences atopy through its effects on sex hormones is suggested by a more frequent link between atopy and obesity in women, particularly postpuberal. Further research should be conducted on the influence of weight gain on atopy and atopic diseases.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Estradiol, meets USP testing specifications
Supelco
Estradiol, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Estradiol, United States Pharmacopeia (USP) Reference Standard